Due to severe weather conditions in the Dallas area, The Dallas CVI symposium is being rescheduled to take place on January 18, 2014
The goal of the 2016 Dallas Cardiovascular Innovations (Dallas CVI) Symposium is to highlight coronary, peripheral, structural, electrophysiologic and pharmacotherapy interventions that have reshaped the treatment of heart and vascular disease today. The focus of this scientific meeting is to bring the most innovative approved treatment options available for patients with cardiovascular disease to health care providers, not only in North Texas, but to a national and international audience. By inviting world renowned thought leaders in the field of cardiovascular medicine, Dallas CVI provides a unique platform for interactive and thoughtful discussions between healthcare providers, researchers and medical industry representatives on modalities to address the current gaps in our knowledgebase and treatment paradigms. The program will provide participants with in-depth education and state-of-the-art management information on how to optimally evaluate and treat patients with peripheral vascular disease, coronary artery disease, valvular heart disease, and arrhythmic heart disease.
Upon completion of this course, participants should be able to:
The 2016 Dallas Cardiovascular Innovations Symposium has been designed to meet the needs of Interventional Cardiologists, Clinical Cardiologists, Internists, Residents, Fellows in Training, Nurses, Nurse Practitioners, Physician Assistants, Pharmacists, and other Health Care providers and Investigators who participate in the management of patients with coronary, peripheral, structural, and arrhythmic cardivascular disease.
THE 2016 DALLAS CARDIOVASCULAR INNOVATIONS SYMPOSIUM
IS DEDICATED TO THE MEMORY OF OWEN OBEL, MD